![]() |
|
|
Vol. 61, Issue 6, 1416-1422, June 2002
3,
4,
2, and
4 Nicotinic Acetylcholine Receptor Subunits Influence the Efficacy
and Potency of Nicotine
Department of Neuroscience, University of Pennsylvania Medical
School, Philadelphia, Pennsylvania
The first three transmembrane segments (M1-M3) of human nicotinic
acetylcholine receptors (nAChRs) have been implicated in determining the efficacy of nicotine by studies of
3/
4 subunit chimeras (Kuryatov et al., 2000a). Nicotine has full efficacy on the
4
2 nAChR and partial efficacy on the
3
2 nAChR. Now, we have
exchanged individually three amino acids between the
4 and the
3
subunits at positions 226(M1), 258(M2), and 262(M2). Also, similar
exchanges were made in the
2 and
4 subunits at positions 224(M1),
226(M1), and 254(M2) (using
subunit numbering). Expression of these
mutated nAChRs in Xenopus laevis oocytes showed that the
mutated M1 amino acids were important in influencing the potency of ACh
and nicotine. It is hypothesized that these M1 amino acids affect the
stability between the resting and activated states of the nAChR. M2
amino acids altered the efficacy of nicotine, usually without altering
its potency. When the residue located at position 258 in the M2 region
of the
subunit was valine (as in the
3 subunit), the resulting
nAChR exhibited partial efficacy for nicotine that was
voltage-dependent. Therefore, we believe that these M2 amino acids
contribute to the formation of a binding site for nicotine in the
3
2 nAChR channel, which results in a low-affinity channel block,
causing the lower efficacy of nicotine on this nAChR.
This article has been cited by other articles:
![]() |
J. K. Staley, S. Krishnan-Sarin, K. P. Cosgrove, E. Krantzler, E. Frohlich, E. Perry, J. A. Dubin, K. Estok, E. Brenner, R. M. Baldwin, et al. Human Tobacco Smokers in Early Abstinence Have Higher Levels of beta2* Nicotinic Acetylcholine Receptors than Nonsmokers. J. Neurosci., August 23, 2006; 26(34): 8707 - 8714. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moroni, R. Zwart, E. Sher, B. K. Cassels, and I. Bermudez {alpha}4beta2 Nicotinic Receptors with High and Low Acetylcholine Sensitivity: Pharmacology, Stoichiometry, and Sensitivity to Long-Term Exposure to Nicotine Mol. Pharmacol., August 1, 2006; 70(2): 755 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Abdrakhmanova, L. Cleemann, J. Lindstrom, and M. Morad Differential Modulation of {beta}2 and {beta}4 Subunits of Human Neuronal Nicotinic Acetylcholine Receptors by Acidification Mol. Pharmacol., August 1, 2004; 66(2): 347 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Salminen, K. L. Murphy, J. M. McIntosh, J. Drago, M. J. Marks, A. C. Collins, and S. R. Grady Subunit Composition and Pharmacology of Two Classes of Striatal Presynaptic Nicotinic Acetylcholine Receptors Mediating Dopamine Release in Mice Mol. Pharmacol., June 1, 2004; 65(6): 1526 - 1535. [Abstract] [Full Text] [PDF] |
||||